A Month To Fear – And Prepare For
Many market players fear the month of October – and not without good reason. However, September may be the month to fear more. Here’s why… Read More »A Month To Fear – And Prepare For
Many market players fear the month of October – and not without good reason. However, September may be the month to fear more. Here’s why… Read More »A Month To Fear – And Prepare For
In May, Canopy Growth became the first marijuana stock to trade on the NYSE. Here, the company’s CEO (the self-proclaimed “world’s biggest legal-weed dealer”) shares… Read More »Marijuana Musings From The “World’s Biggest Legal-Weed Dealer”
With healthcare ETFs displaying positive momentum (and a plethora of reasons to believe that this momentum will continue), this triple-leveraged healthcare ETF could be an… Read More »A Triple Dose Of Healthcare Momentum
A dead money stock is one going nowhere (up or down) in the short-term. With this trading strategy, however, you can generate a sizable return… Read More »Get A Healthy Return From A Dead Money Stock
It’s not buy-and-hold investing. And it’s not day trading (but it may be a good way to ease into it). Here’s a primer on swing… Read More »Get A Handle On Swing Trading
This under-the-radar cannabis company is taking a different approach from most – choosing to be the big fish in small ponds. Here’s why its strategy… Read More »An “Unassuming” Cannabis Company With A “Big Fish” Strategy
Small-cap stocks have been one of the hottest trades of the year. Here’s how the managers of two outperforming small-cap funds select their stocks –… Read More »Cracking The Small-Cap Code
Do companies led by women outperform the market? Here’s what a pair of researchers found when they examined the data – and the most important… Read More »The Facts About Female-Led Firms
They’re the other side of socially responsible investments: sin stocks. Here’s why cannabis, gambling, alcohol and tobacco stocks (among others) can make sense to own… Read More »Socially Irresponsible Investing
As the second-quarter earnings season gets underway, these three healthcare stocks – including a biotech that now has a near monopoly on the cystic fibrosis… Read More »Tip Top Healthcare Bets From Top Analysts